Biopharma scientists are under pressure to accelerate development timelines for complex biologics and genomic medicines by closing the developability gap early to de-risk late-stage manufacturing failures. To do this, they rapidly need to gain deeper insight into molecule’s structural liabilities and their impact on its function.
Watch our specially curated series of on-demand webinars to discover technologies and workflows to help you accelerate the development pace of your next generation biotherapeutics.
Accelerate development timelines with robust and highly efficient workflows for complex biologics
Discover analytics that will show you how to improve your production for challenging genetic therapies, such as oligonucleotides and AAVs
Learn about how electron-activated dissociation (EAD) enables comprehensive identification and characterization of your most challenging product quality attributes